18F-fluoro-2-deoxy-D-glucose positron emission tomographic imaging: recent developments in head and neck cancer

2005 ◽  
Vol 17 (3) ◽  
pp. 249-253 ◽  
Author(s):  
Kristoff Muylle ◽  
Catherine Castaigne ◽  
Patrick Flamen
Skull Base ◽  
1992 ◽  
Vol 2 (04) ◽  
pp. 186-190 ◽  
Author(s):  
Dennis Lee ◽  
Natan Scher ◽  
Saeid Mojtahedi ◽  
Malcolm Cooper ◽  
William R. Panje

2007 ◽  
Vol 82 ◽  
pp. S5-S6
Author(s):  
W. Oyen ◽  
D. Schinagl ◽  
W. Vogel ◽  
B. Wensing ◽  
E. Troost ◽  
...  

2020 ◽  
Vol 11 (SPL4) ◽  
pp. 2777-2784
Author(s):  
Dana Merin ◽  
Roshni P R

This review mainly focuses on the distinct imaging techniques in for head and neck cancer (HNC), its altered techniques used in diagnosis and its applications. It also depicts the upcoming imaging methods present in the field of HNC causing areas. It explains precise determination regarding the degree and extends of neoplasm. We mainly look on to the MRI(Magnetic resonance imaging), PET(Positron emission tomography), CT (computed tomography)imaging biomarkers for the management of HNC. It plays an important role in the therapy selection strategies and also enhances the therapeutic ratio in the management of HNC. The role of imaging techniques become increasingly more crucial in the management process in locally progressed head and neck squamous cell carcinoma(HNSCC). In this structure, PET allows non-invasive assessment of a range of tumour biomarkers such as metabolism, hypoxia and proliferation. MRI techniques such as can characterize different tissues by probing into their microstructure, providing a novel methodology in oncological imaging. CT, MRI, and PET/CT are widely used to determine the presence and extent of the tumours before and after treatment. This review depicts a synopsis of the most recent imaging strategies and imaging recommendations for every one of the different strides along the clinical way of patients with head and neck malignant growth.


Sign in / Sign up

Export Citation Format

Share Document